NASDAQ · OMHealthcareElectromedical Equipment

Outset Medical financials

$3.03+2.36%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
FY20
Dec 31
Revenue$119.5M$113.7M$130.4M$115.4M$102.6M$49.9M
Gross profit$46.8M$38.6M$29.0M$17.8M$7.6M-$13.0M
Gross margin39.1%33.9%22.2%15.5%7.4%−26.1%
Operating income-$66.7M-$113.4M-$169.8M-$161.0M-$130.5M-$117.5M
Net income-$81.7M-$128.0M-$172.8M-$163.0M-$131.9M-$79.3M
Net margin−68.3%−112.6%−132.5%−141.2%−128.6%−158.9%
Diluted EPS$-5.37$-36.96$-52.28$-50.70$-43.35$-72.75
EBITDA-$62.4M-$107.6M-$164.0M-$155.8M-$125.4M-$114.3M
Operating cash flow-$46.3M-$116.3M-$131.4M-$145.7M-$130.3M-$99.0M
Free cash flow-$47.1M-$117.2M-$134.8M-$154.1M-$133.4M-$108.1M
Diluted shares15.2M3.5M3.3M3.2M3.0M1.1M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$35.0M$124.0M$68.5M$73.2M$182.3M$295.0M
Short-term investments$133.9M$34.7M$134.8M$214.3M$157.1M$19.9M
Total debt$96.2M$197.4M$130.1M$96.3M$29.8M$29.7M
Total assets$264.5M$275.8M$313.8M$400.1M$463.5M$403.8M
Total liabilities$137.5M$249.0M$190.9M$154.1M$89.4M$75.2M
Shareholders' equity$127.0M$26.8M$122.9M$246.0M$374.1M$328.6M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology